New Products

Premium

BAC this week launched its CaptureSelect HumanPlasma14 product for the specific, reproducible depletion of the 14 most abundant proteins in human blood plasma or serum.

The product, which uses single-domain monospecific antibodies immobilized on high-capacity agarose-based beads, is intended for preparing samples for downstream analysis by applications like gel electrophoresis and mass spectrometry. It enables the single-step, single-use depletion of more than 99 percent of the targeted protein, the company said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.